11:23 AM EDT, 06/21/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending lower late Friday morning, declining 0.44% to 1,415.88 on the S&P Europe Select ADR Index. Despite the loss, the index is poised to end the week up about 0.61%.

From continental Europe, the gainers were led by semiconductor Sequans Communications ( SQNS ) and biotech firm Evaxion Biotech ( EVAX ) , which rose 7.5% and 3.6% respectively. They were followed by pharmaceutical company Ascendis Pharma ( ASND ) , which increased 2.5%, and hotel booking site trivago (TRVG), up 2%.

The decliners from continental Europe were led by biopharmaceutical company Cellectis ( CLLS ) and financial services company Banco Santander (SAN), which fell 1.8% and 2.5% respectively. They were followed by biopharmaceutical company Genfit ( GNFT ) and financial services company Banco Bilbao Vizcaya Argentaria ( BBVA ) , which dropped 2.2% and 2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and biotech firm Autolus Therapeutics ( AUTL ) , which climbed 13% and 1.2% respectively. They were followed by pharmaceutical companies Silence Therapeutics ( SLN ) , up 0.5%, and AstraZeneca ( AZN ) , which climbed 0.7%.

The decliners from the UK and Ireland were led by biopharmaceutical company Mereo BioPharma Group ( MREO ) , which lost 2.7%, and financial services company Barclays ( JJCTF ) ,down 2.6%. They were followed by biotech firm Trinity Biotech ( TRIB ) , which fell 2.2%, and communications company WPP ( WPP ) , down 1.9%.